We use cookies for a better user experience. Read our Privacy Policy

I Agree

Allergy Immunotherapy Market

Allergy Immunotherapy Market (Treatment Type - Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT); Allergy Type - Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy; Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Allergy Immunotherapy Market – Snapshot

The global allergy immunotherapy market is expanding at a considerable pace due to high prevalence and rise in incidences of allergies across the globe. The global allergy immunotherapy market was valued at US$ 1.37 Bn in 2016 and is projected to expand at CAGR of 10.7% from 2017 to 2025 to exceed the US$ 3.33 Bn by 2025. Expansion of the global allergy immunotherapy market is attributed to the rise in awareness regarding allergy treatment, rapidly growing allergic population, and launch of new products.

Allergy immunotherapy, also referred to as desensitization or hypo-sensitization, is a medical treatment targeted for different types of allergies. There is an increase in prevalence of allergy and pharmacotherapy alone is insufficient to control the disease. The allergy immunotherapeutic treatment helps increase immunological tolerance and alters the disease course. The desensitization therapy provides long-term effect, which extends past the conclusion of treatment. This therapy helps improve the quality of life of patients with allergies.

allergy-immunotherapy-market.jpg

As per the World Allergy Organization (WAO), there has been a significant rise in prevalence of allergic diseases across the world in last 50 years. According to Summary Health Statistics for U.S. Adults: 2010 National Health Interview Survey, over 8% and 13% of adult people in the U.S. have hay fever and sinusitis, respectively. According to WAO, around 30% of the global population suffers from allergic rhinitis alone. Thereby, high prevalence and incidence rate of allergy across the globe are driving the global allergy immunotherapy market. Additionally, increase in awareness about allergy treatment and high clinical R&D budget by governments and non-profit organizations are projected to fuel the allergy immunotherapy market during the forecast period. Promising product pipeline creates opportunities for business development during the forecast period. Across the world, there are around 10 different drugs in phase-3 of the clinical pipeline studies for treating different allergy symptoms.

The subcutaneous immunotherapy (SCIT), is extensively used and effective form of allergy immunotherapy. The SCIT treatment alters the immune system, thereby preventing the development of new allergies and asthma. Allergy tablets are a type of SLIT that treat certain allergies. These allergy tablets decrease the symptoms by helping the body build resistance to allergen effects. However, tablets can only treat a single type of allergen and do not avoid new allergies development and asthma. In 2014, the US Food and Drug administration (FDA) approved SLIT tablets to treat ragweed and grass pollen allergies.

The global allergy immunotherapy market is divided into four segments based on treatment type, allergy type, distribution channel, and geography. In terms of treatment type, the global allergy immunotherapy market is segmented into SCIT and SLIT. SCIT dominated the global allergy immunotherapy market in 2016, account for more than 65% share of the market. The segment is projected to expand at a moderate pace and gain market share during the forecast period.

In terms of allergy type, the global allergy immunotherapy market is classified into allergic rhinitis, asthma, food allergy, venom allergy, and others. The allergic rhinitis segment accounted for a leading share of the global market. The segment is projected to continue its dominance during the forecast period. The asthma segment accounted for a significant share of the market due to effectiveness of SCIT and SLIT in the treatment of allergic asthma. The other segment includes allergies such as latex allergy, pollen allergy, and mold allergy. Distribution channels include hospital pharmacies, retail pharmacies & drug stories, and online pharmacies. The hospital pharmacies segment dominated the global allergy immunotherapy market in 2016 and is likely to gain share by the end of 2025.

Geographically, the allergy immunotherapy market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe accounted for the largest share of the global allergy immunotherapy market in 2016, followed by North America. Europe accounts for a large share of the market due to high awareness, increase in funding for research and grants, favorable medical reimbursement policies, rise in allergic population, and promising clinical pipeline products. The region is a highly attractive market and is anticipated to expand at a significant CAGR during the forecast period. The allergy immunotherapy market in Asia Pacific is anticipated to expand at a moderate growth rate. Majority of the market share of allergy immunotherapy is captured by Japan and China in Asia-Pacific region, owing to the presence of huge allergic population in these countries.

The global allergy immunotherapy market is consolidated with some companies accounting for majority share. Leading players operating in the global allergy immunotherapy market include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Merck KGaA (Allergopharma),  and HAL Allergy Group. Manufacturers are adopting new SLIT therapies commercialization in the international market to tap the unmet needs of allergy immunotherapy. Other prominent players operating in the global market include Biomay AG, Anergis, Aimmune Therapeutics, Circassia and DBV Technologies.

The global allergy immunotherapy market has been segmented as follows:

Treatment Type

  • SCIT (Subcutaneous Immunotherapy)
  • SLIT (Sublingual Immunotherapy)

Allergy Type

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy and Drug Stores
  • Online Pharmacy

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

    Chapter 1 Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

    Chapter 2 Assumptions and Research Methodology

    Chapter 3 Executive Summary: Global Allergy Immunotherapy Market

    Chapter 4 Market Overview
    4.1. Introduction
    4.2. Key Industry Developments

    Chapter 5 Market Dynamics
    5.1. Drivers
    5.2. Restraints
    5.3. Opportunities
    5.4. Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
    5.5. Global Allergy Immunotherapy Market Outlook

    Chapter 6 Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment Type
    6.1. Key Findings
    6.2. Introduction
    6.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
           6.3.1. Subcutaneous Immunotherapy (SCIT)
           6.3.2. Sublingual Immunotherapy(SLIT)
    6.4. Market Attractiveness Analysis, by Treatment Type

    Chapter 7 Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type
    7.1. Key Findings
    7.2. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
           7.2.1. Allergic Rhinitis
           7.2.2. Asthma
           7.2.3. Food Allergy
           7.2.4. Venom Allergy
           7.2.5. Others
    7.3. Market Attractiveness Analysis, by Allergy Type
    7.4. Key Trends

    Chapter 8 Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel
    8.1. Key Findings
    8.2. Introduction
    8.3. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
           8.3.1. Hospital Pharmacy
           8.3.2. Retail Pharmacy and Drug Stores
           8.3.3. Online Pharmacy
    8.4. Market Attractiveness Analysis, by Distribution Channel

    Chapter 9 Global Allergy Immunotherapy Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Global Market Scenario
    9.3. Market Value (US$ Mn) Forecast, by Region, 2017–2025
           9.3.1. North America
           9.3.2. Europe
           9.3.3. Asia Pacific
           9.3.4. Latin America
           9.3.5. Middle East & Africa
    9.4. Market Attractiveness Analysis, by Region

    Chapter 10 North America Allergy Immunotherapy Market Analysis and Forecast
    10.1. Key Findings
    10.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
           10.2.1. U.S.
           10.2.2. Canada
    10.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
           10.3.1. SCIT
           10.3.2. SLIT
    10.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
           10.4.1. Allergic Rhinitis
           10.4.2. Asthma
           10.4.3. Food Allergy
           10.4.4. Venom Allergy
           10.4.5. Other
    10.5. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
           10.5.1. Hospital Pharmacy
           10.5.2. Retail Pharmacy and Drug Stores
           10.5.3. Online Pharmacy
    10.6. Market Attractiveness Analysis
           10.6.1. By Country
           10.6.2. By Treatment Type
           10.6.3. By Allergy Type
           10.6.4. By Distribution Channel

    Chapter 11 Europe Allergy Immunotherapy Market Analysis and Forecast
    11.1. Key Findings
    11.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
           11.2.1. Germany
           11.2.2. U.K.
           11.2.3. France
           11.2.4. Italy
           11.2.5. Spain
           11.2.6. Russia
           11.2.7. Rest of Europe
    11.3. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
           11.3.1. SCIT
           11.3.2. SLIT
    11.4. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
           11.4.1. Allergic Rhinitis
           11.4.2. Asthma
           11.4.3. Food Allergy
           11.4.4. Venom Allergy
           11.4.5. Others
    11.5. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
           11.5.1. Hospital Pharmacy
           11.5.2. Retail Pharmacy and Drug Stores
           11.5.3. Online Pharmacy
    11.6. Market Attractiveness Analysis
           11.6.1. By Country
           11.6.2. By Treatment Type
           11.6.3. By Allergy Type
           11.6.4. By Distribution Channel

    Chapter 12 Asia Pacific Allergy Immunotherapy Market Analysis and Forecast
    12.1. Key Findings / Developments
    12.2. Market Overview
    12.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
           12.3.1. China
           12.3.2. India
           12.3.3. Japan
           12.3.4. Australia & New Zealand
           12.3.5. Rest of Asia Pacific
    12.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
           12.4.1. SCIT
           12.4.2. SLIT
    12.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
           12.5.1. Allergic Rhinitis
           12.5.2. Asthma
           12.5.3. Food Allergy
           12.5.4. Venom Allergy
           12.5.5. Others
    12.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
           12.6.1. Hospital Pharmacy
           12.6.2. Retail Pharmacy and Drug Stores
           12.6.3. Online Pharmacy
    12.7. Market Attractiveness Analysis
           12.7.1. By Country
           12.7.2. By Treatment Type
           12.7.3. By Allergy Type
           12.7.4. By Distribution Channel

    Chapter 13 Latin America Allergy Immunotherapy Market Analysis and Forecast
    13.1. Key Findings / Developments
    13.2. Market Overview
    13.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
           13.3.1. Brazil
           13.3.2. Mexico
           13.3.3. Rest of Latin America
    13.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
           13.4.1. SCIT
           13.4.2. SLIT
    13.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017-2025
           13.5.1. Allergic Rhinitis
           13.5.2. Asthma
           13.5.3. Food Allergy
           13.5.4. Venom Allergy
           13.5.5. Others
    13.6. Market Size (US$ Mn) Forecast by Distribution Channel, 2017–2025
           13.6.1. Hospital Pharmacy
           13.6.2. Retail Pharmacy and Drug Stores
           13.6.3. Online Pharmacy
    13.7. Market Attractiveness Analysis
           13.7.1. By Country/Sub-region
           13.7.2. By Treatment Type
           13.7.3. By Allergy Type
           13.7.4. By Distribution Channel

    Chapter 14 Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast
    14.1. Key Findings / Developments
    14.2. Market Overview
    14.3. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
           14.3.1. GCC Countries
           14.3.2. South Africa
           14.3.3. Israel
           14.3.4. Rest of Middle East & Africa
    14.4. Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
           14.4.1. SCIT
           14.4.2. SLIT
    14.5. Market Size (US$ Mn) Forecast, by Allergy Type, 2017–2025
           14.5.1. Allergic Rhinitis
           14.5.2. Asthma
           14.5.3. Food Allergy
           14.5.4. Venom Allergy
           14.5.5. Others
    14.6. Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
           14.6.1. Hospital Pharmacy
           14.6.2. Retail Pharmacy and Drug Stores
           14.6.3. Online Pharmacy
    14.7. Market Attractiveness Analysis
           14.7.1. By Country/Sub-region
           14.7.2. By Treatment Type
           14.7.3. By Allergy Type
           14.7.4. By Distribution Channel

    Chapter 15 Pipeline Analysis
           15.1.1. Allergy Immunotherapy Pipeline Analysis (2017)

    Chapter 16 Allergy Immunotherapy – Regulatory Overview
           16.1.1. Regulatory Status for European Union
           16.1.2. Regulatory Status for U.S.

    Chapter 17 Competition Landscape
    17.1. Global Allergy Immunotherapy Market Share, by Company, 2017
    17.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
           17.2.1. ALK-Abello A/S
                     17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.1.2. Product Portfolio
                     17.2.1.3. SWOT Analysis
                     17.2.1.4. Strategic Overview
           17.2.2. Allergy Therapeutics
                     17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.2.2. Product Portfolio
                     17.2.2.3. SWOT Analysis
                     17.2.2.4. Strategic Overview
           17.2.3. Stallergenes Greer
                     17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.3.2. Product Portfolio
                     17.2.3.3. SWOT Analysis
                     17.2.3.4. Financial Overview
                     17.2.3.5. Strategic Overview
           17.2.4. HAL Allergy Group
                     17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.4.2. Product Portfolio
                     17.2.4.3. SWOT Analysis
                     17.2.4.4. Financial Overview
                     17.2.4.5. Strategic Overview
           17.2.5. DBV Technologies
                     17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.5.2. Product Portfolio
                     17.2.5.3. SWOT Analysis
                     17.2.5.4. Financial Overview
                     17.2.5.5. Strategic Overview
           17.2.6. Merck KGaA
                     17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.6.2. Product Portfolio
                     17.2.6.3. SWOT Analysis
                     17.2.6.4. Financial Overview
                     17.2.6.5. Strategic Overview
           17.2.7. Aimmune Therapeutics
                     17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.7.2. Product Portfolio
                     17.2.7.3. SWOT Analysis
                     17.2.7.4. Financial Overview
                     17.2.7.5. Strategic Overview
           17.2.8. Circassia
                     17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.8.2. Product Portfolio
                     17.2.8.3. SWOT Analysis
                     17.2.8.4. Financial Overview
                     17.2.8.5. Strategic Overview
           17.2.9. Anergis
                     17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.9.2. Product Portfolio
                     17.2.9.3. SWOT Analysis
                     17.2.9.4. Financial Overview
                     17.2.9.5. Strategic Overview
           17.2.10. Biomay AG
                     17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.10.2. Product Portfolio
                     17.2.10.3. SWOT Analysis
                     17.2.10.4. Financial Overview
                     17.2.10.5. Strategic Overview

    List of Tables

    Table 01: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 02: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 03: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
    Table 04: Global Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Region, 2015–2025
    Table 05: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 06: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel , 2015–2025
    Table 07: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
    Table 08: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 09: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
    Table 10: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 11: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 12: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 13: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
    Table 14: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 15: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
    Table 16: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 17: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Types, 2015–2025
    Table 18: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 19: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 20: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 21: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
    Table 22: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 23: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
    Table 24: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2015–2025

    List of Figures

    Figure 01: Market Snapshot 
    Figure 02: Market Value Share By Treatment Type (2017) Value (US$ Mn)
    Figure 03: Market Value Share By Allergy Type (2017) Value (US$ Mn)
    Figure 04: Market Value Share By Distribution Channel (2017) Value (US$ Mn)
    Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Type, 2016 and 2025
    Figure 06: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SCIT, 2015–2025
    Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by SLIT, 2015–2025
    Figure 8: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
    Figure 09: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 10: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2015–2025
    Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2015–2025
    Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies and Drug Store, 2015–2025
    Figure 13: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 14: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
    Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allergic Rhinitis, 2015–2025
    Figure 16: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2015–2025
    Figure 17: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Food Allergy, 2015–2025
    Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Venom Allergy, 2015–2025
    Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2027
    Figure 20: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type , 2017–2025
    Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2016 and 2025
    Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2017–2025
    Figure 23: North America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
    Figure 24: North America Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025
    Figure 25: North America Allergy Immunotherapy Market Attractiveness, by Country, 2017–2025
    Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
    Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
    Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 30: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
    Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
    Figure 32: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2016 and 2025
    Figure 33: Europe Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
    Figure 34: Europe Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025
    Figure 35: Europe Allergy Immunotherapy Market Attractiveness, by Country, 2016
    Figure 36: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
    Figure 37: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
    Figure 38: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
    Figure 39: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
    Figure 40: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 41: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 42: Europe Allergy Immunotherapy Market, by Country, 2016 and 2025
    Figure 43: Asia Pacific Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
    Figure 44: Asia Pacific Allergy Immunotherapy Market Y-o-Y Growth Projections, 2016–2025
    Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness, by Country, 2016
    Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
    Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
    Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
    Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
    Figure 50: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 51: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 52: Asia Pacific Surgical Drapes Market, by Country, 2016 and 2025
    Figure 53: Latin America Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
    Figure 54: Latin America Allergy Immunotherapy Y-o-Y Growth Projections, 2016–2025
    Figure 55: Latin America Allergy Immunotherapy Market Attractiveness, by Country, 2016
    Figure 56: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
    Figure 57: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
    Figure 58: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
    Figure 59: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
    Figure 60: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 61: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 62: Latin America Allergy Immunotherapy Market, by Country, 2016 and 2025
    Figure 63: Middle East & Africa Allergy Immunotherapy Market Size (US$ Mn) Forecast, 2015–2025
    Figure 64: Middle East & Africa Allergy Immunotherapy Y-o-Y Growth (%) Projection, 2016–2025
    Figure 65: Middle East & Africa Allergy Immunotherapy Market Attractiveness, by Country, 2017-2025
    Figure 66: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2016 and 2025
    Figure 67: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2017–2025
    Figure 68: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment Type, 2016 and 2025
    Figure 69: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment Type, 2017–2025
    Figure 70: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2016 and 2025
    Figure 71: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 72: Middle East & Africa Allergy Immunotherapy Market, by Country, 2016 and 2025
    Figure 73: Global Allergy Therapeutics Market Share Analysis, by Company (2017)
    Figure 74: ALK-Abello A/S Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 75: ALK-Abello A/S Global Operating Profit (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 76: ALK-Abello A/S Breakdown of Net Sales, by Region, 2017
    Figure 77: ALK-Abello A/S Breakdown of Net Sales, by Business Segment, 2017
    Figure 78: Allergy Therapeutics Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 79: Allergy Therapeutics Breakdown of Net Sales, by Region, 2017
    Figure 80: Allergy Therapeutics Breakdown of Net Sales, by Business Segment, 2017
    Figure 81: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017
    Figure 82: Stallergenes Greer R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 83: Stallergenes Greer Breakdown of Net Sales, by Region, 2017
    Figure 84: Stallergenes Greer Breakdown of Net Sales, by Business Segment, 2017
    Figure 85: Merck KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 86: Merck KGaA R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
    Figure 87: Merck KGaA Breakdown of Net Sales, by Region, 2017
    Figure 88: Merck KGaA Breakdown of Net Sales, by Business Segment, 2017
    Figure 89: Circassia Global Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
    Figure 90: Circassia Global Research and Development Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016

Copyright © Transparency Market Research, Inc. All Rights reserved